Published: 15 January 2018
Author(s): Carlos Andrés Pineda-Cañar, Herney Andrés García-Perdomo
Issue: January 2018
Section: Letter to the Editor

The recently proposed new classification and intervention for hypertension published by the ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Panel [1] have caused lots of controversy since it lowers the cut-off value from 140/90 to 130/80 mm Hg to initiate a pharmacological intervention. This guideline focuses on the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults, however, the main controversy lies on recommending a pharmacological intervention to patients reaching 140/90 mm Hg and people with 130/80 mm Hg and cardiovascular risk higher than 10%.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.